A bacterial extract of OM-85 Broncho-Vaxom suppresses ovalbumin-induced airway inflammation and remodeling in a mouse chronic allergic asthma model

International Journal of Clinical and Experimental Pathology

Volumn 10, Issue 2, 2017, Pages 1149-1157

  Zhong, Hua ^a   Wei, Jiawei ^a   Yao, Yin ^a   Fu, Ran ^a   Li, Hang ^a   Fu, Qingling ^a   Wen, Weiping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Airway remodeling; Allergic asthma; Chronic airway inflammation; OM 85 BV

Indexed keywords

EID: 85014029214     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chung KF. Targeting the interleukin pathway in the treatment of asthma. The Lancet 2015; 386: 1086-1096.
2. Martinez FD and Vercelli D. Asthma. Lancet 2013; 382: 1360-1372.
3. Lemanske RF Jr and Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 2010; 125: S95-102.
4. Al-Muhsen S, Johnson JR and Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011; 128: 451-462; quiz 463-454.
5. Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol 2015; 15: 57-65.
6. Durham AL, Caramori G, Chung KF and Adcock IM. Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease. Transl Res 2016; 167: 192-203.
7. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol 2015; 15: 271-282.
8. Galli SJ and Tsai M. IgE and mast cells in allergic disease. Nat Med 2012; 18: 693-704.
9. Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, Hellings P, Brusselle G, De Bacquer D, van Cauwenberge P and Bachert C. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131: 110-116, e111.
10. Julia V, Macia L and Dombrowicz D. The impact of diet on asthma and allergic diseases. Nat Rev Immunol 2015; 15: 308-322.
11. Bowman LM and Holt PG. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infect Immun 2001; 69: 3719-3727.
12. Han L, Zheng CP, Sun YQ, Xu G, Wen W and Fu QL. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy 2013; [Epub ahead of print].
13. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
14. Solèr M, Mütterlein R, Cozma G; Swiss-German OM-85 Study Group. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Respiration 2007; 74: 26-32.
15. Navarro S, Cossalter G, Chiavaroli C, Kanda A, Fleury S, Lazzari A, Cazareth J, Sparwasser T, Dombrowicz D, Glaichenhaus N and Julia V. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 2011; 4: 53-65.
16. Strickland DH, Judd S, Thomas JA, Larcombe AN, Sly PD and Holt PG. Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol 2011; 4: 43-52.
17. Das G, Fu R, Li J, Zhong H, Yu D, Zeng X, Deng M, Sun Y, Wen W and Li H. Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3ß-related T regulatory cell insufficiency. PLoS One 2014; 9: e92912.
18. Kang JH, Kim BS, Uhm TG, Lee SH, Lee GR, Park CS and Chung IY. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. Am J Respir Crit Care Med 2009; 179: 875-882.
19. Tournoy KG, Kips JC, Schou C, Pauwels RA. Airway eosinophilia is not a requirement for allergen-induced airway. Clin Exp Allergy 2000; 30: 79-85.
20. Ji WJ, Ma YQ, Zhou X, Zhang YD, Lu RY, Guo ZZ, Sun HY, Hu DC, Yang GH, Li YM, Wei LQ. Spironolactone attenuates bleomycin-induced pulmonary injury partially via. PLoS One 2013; 8: e81090.
21. Qiu H, Kuolee R, Harris G, Zhou H, Miller H, Patel GB and Chen W. Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma. PLoS One 2011; 6: e22004.
22. Kavanagh H, Noone C, Cahill E, English K, Locht C and Mahon BP. Attenuated bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy 2010; 40: 933-941.
23. Thorburn AN, O'Sullivan BJ, Thomas R, Kumar RK, Foster PS, Gibson PG and Hansbro PM. Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease. Thorax 2010; 65: 1053-1060.
24. Cockcroft DW and Davis BE. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 2006; 118: 551-559; quiz 560-551.
25. Durrani SR, Viswanathan RK and Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol 2011; 128: 439-448; quiz 449-450.
26. Southam DS, Ellis R, Wattie J, Glass W and Inman MD. Goblet cell rebound and airway dysfunction with corticosteroid withdrawal in a mouse model of asthma. Am J Respir Crit Care Med 2008; 178: 1115-1122.
27. Annunziato F, Romagnani C and Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 2015; 135: 626-635.
28. Fajt ML and Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 2015; 135: 299-310; quiz 311.
29. Oeser K, Maxeiner J, Symowski C, Stassen M and Voehringer D. T cells are the critical source of IL-4/IL-13 in a mouse model of allergic asthma. Allergy 2015; 70: 1440-9.
30. Yang M, Du Y, Xu Z and Jiang Y. Functional effects of WNT1-inducible signaling pathway protein-1 on bronchial smooth muscle cell migration and proliferation in OVA-induced airway remodeling. Inflammation 2016; 39: 16-29.